Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-36,858
Closed -$2.87M 219
2021
Q2
$2.87M Sell
36,858
-1,664
-4% -$124K 0.4% 56
2021
Q1
$2.83M Buy
38,522
+5,391
+16% +$398K 0.41% 53
2020
Q4
$2.59M Hold
33,131
0.4% 49
2020
Q3
$2.62M Buy
33,131
+1,716
+5% +$134K 0.49% 39
2020
Q2
$2.32M Sell
31,415
-3,181
-9% -$239K 0.46% 42
2020
Q1
$2.54M Buy
+34,596
New +$2.72M 0.61% 38

Other funds holding MRK

Connable Office Inc's MRK Position: Q3 2021 in Review

Connable Office Inc sold out of Merck (MRK) in Q3 2021, closing a stake of 36,858 shares — an estimated $2.87M sold.

Connable Office Inc first reported a position in MRK in Q1 2020 and held it in 6 quarters. The position peaked at $2.87M in Q2 2021. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Connable Office Inc reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
  • Connable Office Inc sold 36,858 Merck shares in Q3 2021, an estimated $2.87M.
  • Connable Office Inc first reported a position in Merck in Q1 2020 and held it in 6 quarters.
  • Connable Office Inc's Merck position peaked at $2.87M in Q2 2021.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Connable Office Inc's 13F filing for Q3 2021, filed 9 Nov 2021.